{
  "url": "https://finance.yahoo.com/news/digital-biomarkers-global-markets-report-094800528.html?_guc_consent_skip=1756374841",
  "authorsByline": "Research and Markets",
  "articleId": "1cf4e7df8307411a8c753ae8a26cb66f",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/globenewswire.com/63ce759f71de04244cc1ab8535b5fe68",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-28T09:48:00+00:00",
  "addDate": "2025-08-28T09:55:46.396394+00:00",
  "refreshDate": "2025-08-28T09:55:46.396395+00:00",
  "score": 1.0,
  "title": "Digital Biomarkers Global Markets Report 2025",
  "description": "The global digital biomarkers market is set to grow from $5 billion in 2025 to $18.8 billion by 2030, with a CAGR of 30.4%. This report analyzes trends, ESG developments, and emerging technologies. It offers insights on market size, drivers, challenges, and profiles leading companies like Actigraph LLC and AliveCor Inc. Digital Biomarkers Market Digital Biomarkers Market Dublin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The \"Digital Biomarkers: Global Markets\" report has been added to ResearchAndMarkets",
  "content": "The global digital biomarkers market is set to grow from $5 billion in 2025 to $18.8 billion by 2030, with a CAGR of 30.4%. This report analyzes trends, ESG developments, and emerging technologies. It offers insights on market size, drivers, challenges, and profiles leading companies like Actigraph LLC and AliveCor Inc.\n\nDublin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The \"Digital Biomarkers: Global Markets\" report has been added to ResearchAndMarkets.com's offering.\n\n\n\nThe global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030. \n\n\n\nThis report provides an overview of the global market for digital biomarkers and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030.\n\nThe market is segmented based on system components, applications, therapeutic areas, end users and regions. The regions covered in this study include North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries in these regions. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and governance (ESG) developments and discusses emerging technologies related to the market.\n\n\n\nThe report includes:\n\u2022 An overview of the global market for digital biomarkers\n\u2022 Estimation of the market size and analyses of global market trends, with data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030\n\u2022 Information regarding major market drivers, opportunities and challenges, industry chain structure, distribution channel and technological advancements that are affecting the overall market\n\u2022 Evaluation of market potential and revenue forecast for the digital biomarkers market based on system component, application, therapeutic area, end user and region\n\u2022 Insights into the industry structure, current competitive scenario, R&D activities, growth strategies and ESG trends of the market\n\u2022 Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, joint ventures and strategic alliances\n\u2022 Profiles of the leading companies, including Actigraph LLC., AliveCor Inc., Altoida, Evidation Health Inc., and IXICO Plc.",
  "medium": "Article",
  "links": [
    "https://www.researchandmarkets.com/reports/5561559/digital-biomarkers-global-markets?utm_source=GNE&utm_medium=PressRelease&utm_code=zkwvjg&utm_campaign=2087417+-+Digital+Biomarkers+Global+Markets+Report+2025+%7c+Rising+Adoption+of+Mhealth+Apps+and+Wearables%2c+Growing+Application+in+Neurodegenerative+and+Psychiatric+Disorders%2c+Increasing+Role+in+Clinical+Trials&utm_exec=chdomspi"
  ],
  "labels": [
    {
      "name": "Roundup"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "global market trends",
      "weight": 0.12088495
    },
    {
      "name": "market trends",
      "weight": 0.1166788
    },
    {
      "name": "major market drivers",
      "weight": 0.10873018
    },
    {
      "name": "market size",
      "weight": 0.10739557
    },
    {
      "name": "market potential",
      "weight": 0.10420698
    },
    {
      "name": "digital biomarkers",
      "weight": 0.08612923
    },
    {
      "name": "ESG trends",
      "weight": 0.08391138
    },
    {
      "name": "compound annual growth rates",
      "weight": 0.078817196
    },
    {
      "name": "The global digital biomarkers market",
      "weight": 0.07807906
    },
    {
      "name": "AliveCor Inc.",
      "weight": 0.076730266
    }
  ],
  "topics": [],
  "categories": [
    {
      "name": "Business"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.927734375
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.91748046875
    },
    {
      "name": "/News/Business News/Other",
      "score": 0.8896484375
    },
    {
      "name": "/Business & Industrial/Advertising & Marketing/Marketing",
      "score": 0.7724609375
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.491455078125
    }
  ],
  "sentiment": {
    "positive": 0.385189,
    "negative": 0.046094205,
    "neutral": 0.5687168
  },
  "summary": "The global digital biomarkers market is predicted to grow from $5 billion in 2025 to $18.8 billion by 2030, with a CAGR of 30.4%. The report provides an overview of the global market for digital biomarker and analyzes market trends, trends, developments, and emerging technologies. It also profiles leading companies like Actigraph LLC and AliveCor Inc. The market is segmented based on system components, applications, therapeutic areas, and regions. The regions covered include North America, Europe, Asia-Pacific and the Rest of the World.",
  "shortSummary": "The global digital biomarkers market is expected to grow from $5 billion to $18.8 billion by 2030, with a 30.4% CAGR, comprehensive report reveals.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "47c50fd7e7594cb4be9b268b281ad9af",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://www.researchandmarkets.com/reports/5561559/digital-biomarkers-global-markets?utm_source=GNE&utm_medium=PressRelease&utm_code=zkwvjg&utm_campaign=2087417+-+Digital+Biomarkers+Global+Markets+Report+2025+%7c+Rising+Adoption+of+Mhealth+Apps+and+Wearables%2c+Growing+Application+in+Neurodegenerative+and+Psychiatric+Disorders%2c+Increasing+Role+in+Clinical+Trials&utm_exec=chdomspi",
      "text": "Chapter 1 Executive Summary\n- Market Outlook\n- Scope of Report\n- Market Summary\n- Market Growth Factors\n- Emerging Technologies\n- Segmental Analysis\n- Regional Analysis\n- Conclusion\nChapter 2 Market Overview\n- Overview and Market Definition\n- Digital Biomarker Types\n- Comparison of Traditional and Digital Biomarkers\n- Pestel Analysis\n- Political\n- Economic\n- Social\n- Technological\n- Environmental\n- Legal\n- Impact of U.S. Tariff Laws on the Digital Biomarkers Market\n- Increase in Product Costs\n- Effects on Supply Chain\n- Opportunities for Local Production\n- Conclusion\nChapter 3 Market Dynamics\n- Market Dynamics\n- Market Drivers\n- Rising Adoption of Mhealth Apps and Wearables\n- Growing Application of Digital Biomarkers in Neurodegenerative and Psychiatric Disorders\n- Increasing Role of Digital Biomarkers in Clinical Trials\n- Corporate Wellness Programs and Incentives\n- Market Restraints\n- Data Standardization and Interpretation Issues\n- Difficulties in Validation of Biomarkers\n- Data Privacy and Protection\n- Market Opportunities\n- Growing Technology Innovations\n- Increasing Research Collaborations and Partnerships\nChapter 4 Regulatory Landscape\n- Regulatory Scenario\n- The U.S.\n- Canada\n- Europe\n- Asia-Pacific\nChapter 5 Emerging Technologies and Developments\n- Artificial Intelligence-based Digital Biomarkers\n- Enhancement of Digital Biomarkers by AI and ML\n- Benefits of AI-Driven Digital Biomarkers\nChapter 6 Market Segmentation Analysis\n- Segmentation Breakdown\n- Market Breakdown by System Component\n- Key Takeaways\n- Data Collection Tools\n- Data Integration Systems\n- Market Breakdown by Application\n- Key Takeaways\n- Diagnostic Digital Biomarkers\n- Monitoring Digital Biomarkers\n- Predictive Digital Biomarkers\n- Other Applications\n- Market Breakdown by Therapeutic Area\n- Key Takeaways\n- Cardiovascular and Metabolic Disorders\n- Psychiatric Disorders\n- Neurological Disorders\n- Musculoskeletal Disorders\n- Respiratory Disorders\n- Other Therapeutic Areas\n- Market Breakdown by End-user\n- Key Takeaways\n- Pharmaceutical Companies and Research Institutions\n- Healthcare Providers\n- Patients and Caregivers\n- Employers\n- Payers\n- Geographic Breakdown\n- Market Breakdown by Region\n- Key Takeaways\n- North America\n- Europe\n- Asia-Pacific\n- Rest of the World\nChapter 7 Competitive Intelligence\n- Key Takeaways\n- Prominent Digital Biomarkers Companies\n- Competitor Types and Their Strategies\n- Pharmaceutical Companies\n- Large Technology Companies\n- Small and Medium-Size Technology Companies\n- Strategic Analysis\n- Agreements, Collaborations and Partnerships\n- New Product Launches\n- Acquisitions and Mergers\n- Regulatory Approvals\nChapter 8 Sustainability in Digital Biomarkers Market: ESG Perspective\n- Introduction\n- Sustainability Factors\n- Environmental Sustainability\n- Social Sustainability\n- Economic Sustainability\n- Other Factors\n- Scaling Sustainable Practices in Healthcare\n- Business Practices Implementing Sustainable Solutions\n- Conclusion\nList of Tables\nSummary Table: Global Market for Digital Biomarkers, by Application, Through 2030\nTable 1: Digital Biomarker Types\nTable 2: Traditional and Digital Biomarker Comparison\nTable 3: Digital Biomarkers Examples\nTable 4: Technology Innovations by Digital Biomarker Companies\nTable 5: Key Research Collaborations and Partnerships, 2023-2025\nTable 6: Global Market for Digital Biomarkers, by System Component, Through 2030\nTable 7: Global Digital Biomarkers Market for Data Collection Tools, by Type, Through 2030\nTable 8: Global Digital Biomarkers Market for Data Collection Tools, by Region, Through 2030\nTable 9: Global Digital Biomarkers Market for Mobile and Web Apps, by Region, Through 2030\nTable 10: Global Digital Biomarkers Market for Wearables, by Region, Through 2030\nTable 11: Global Digital Biomarkers Market for Implantables and Ingestibles, by Region, Through 2030\nTable 12: Global Digital Biomarkers Market for Other Data Collection Tools, by Region, Through 2030\nTable 13: Global Digital Biomarkers Market for Data Integration Systems, by Region, Through 2030\nTable 14: Global Market for Digital Biomarkers, by Application, Through 2030\nTable 15: Global Market for Diagnostic Digital Biomarkers, by Region, Through 2030\nTable 16: Global Market for Monitoring Digital Biomarkers, by Region, Through 2030\nTable 17: Global Market for Predictive Digital Biomarkers, by Region, Through 2030\nTable 18: Global Market Other Applications of Digital Biomarkers, by Region, Through 2030\nTable 19: Global Market for Digital Biomarkers, by Therapeutic Area, Through 2030\nTable 20: Global Digital Biomarkers Market for Cardiovascular and Metabolic Disorders, by Region, Through 2030\nTable 21: Global Digital Biomarkers Market for Psychiatric Disorders, by Region, Through 2030\nTable 22: Global Digital Biomarkers Market for Neurological Disorders, by Region, Through 2030\nTable 23: Global Digital Biomarkers Market for Musculoskeletal Disorders, by Region, Through 2030\nTable 24: Global Digital Biomarkers Market for Respiratory Disorders, by Region, Through 2030\nTable 25: Global Digital Biomarkers Market for Other Therapeutic Areas, by Region, Through 2030\nTable 26: Global Market for Digital Biomarkers, by End User, Through 2030\nTable 27: Global Digital Biomarkers Market for Pharmaceutical Companies and Research Institutions, by Region, Through 2030\nTable 28: Global Digital Biomarkers Market for Healthcare Providers, by Region, Through 2030\nTable 29: Global Digital Biomarkers Market for Patients and Caregivers, by Region, Through 2030\nTable 30: Global Digital Biomarkers Market for Employers, by Region, Through 2030\nTable 31: Global Digital Biomarkers Market for Payers, by Region, Through 2030\nTable 32: Global Market for Digital Biomarkers, by Region, Through 2030\nTable 33: North American Market for Digital Biomarkers, by System Component, Through 2030\nTable 34: North American Market for Data Collection Tools, by Type, Through 2030\nTable 35: North American Market for Digital Biomarkers, by Application, Through 2030\nTable 36: North American Market for Digital Biomarkers, by Therapeutic Area, Through 2030\nTable 37: North American Market for Digital Biomarkers, by End User, Through 2030\nTable 38: North American Market for Digital Biomarkers, by Country, Through 2030\nTable 39: European Market for Digital Biomarkers, by System Component, Through 2030\nTable 40: European Market for Data Collection Tools, by Type, Through 2030\nTable 41: European Market for Digital Biomarkers, by Application, Through 2030\nTable 42: European Market for Digital Biomarkers, by Therapeutic Area, Through 2030\nTable 43: European Market for Digital Biomarkers, by End User, Through 2030\nTable 44: European Market for Digital Biomarkers, by Country, Through 2030\nTable 45: Asia-Pacific Market for Digital Biomarkers, by System Component, Through 2030\nTable 46: Asia-Pacific Market for Data Collection Tools, by Type, Through 2030\nTable 47: Asia-Pacific Market for Digital Biomarkers, by Application, Through 2030\nTable 48: Asia-Pacific Market for Digital Biomarkers, by Therapeutic Area, Through 2030\nTable 49: Asia-Pacific Market for Digital Biomarkers, by End User, Through 2030\nTable 50: Asia-Pacific Market for Digital Biomarkers, by Country, Through 2030\nTable 51: RoW Market for Digital Biomarkers, by System Component, Through 2030\nTable 52: RoW Market for Data Collection Tools, by Type, Through 2030\nTable 53: RoW Market for Digital Biomarkers, by Application, Through 2030\nTable 54: RoW Market for Digital Biomarkers, by Therapeutic Area, Through 2030\nTable 55: RoW Market for Digital Biomarkers, by End User, Through 2030\nTable 56: RoW Market for Digital Biomarkers, by Sub-Region, Through 2030\nTable 57: Prominent Digital Biomarkers Companies\nTable 58: Agreements, Collaborations and Partnerships in the Digital Biomarkers Market, 2023-2025\nTable 59: New Product Launches in the Digital Biomarkers Market, 2022-2025\nTable 60: Acquisitions and Mergers in the Digital Biomarkers Market, 2024 and 2025\nTable 61: Regulatory Approvals in the Digital Biomarkers Market, 2022-2025\nTable 62: Information Sources for this Report\nTable 63: Abbreviations Used in this Report\nTable 64: ActiGraph LLC.: Company Snapshot\nTable 65: ActiGraph LLC.: Product Portfolio\nTable 66: ActiGraph LLC.: News/Key Developments, 2023-2025\nTable 67: Akili Inc.: Company Snapshot\nTable 68: Akili Inc.: Product Portfolio\nTable 69: Akili Inc.: News/Key Developments, 2024\nTable 70: Alivecor Inc.: Company Snapshot\nTable 71: AliveCor Inc.: Product Portfolio\nTable 72: AliveCor Inc.: News/Key Developments, 2024 and 2025\nTable 73: Altoida: Company Snapshot\nTable 74: Altoida: Product Portfolio\nTable 75: Embic Corp.: Company Snapshot\nTable 76: Embic Corp.: Product Portfolio\nTable 77: Empatica Inc.: Company Snapshot\nTable 78: Empatica Inc.: Product Portfolio\nTable 79: Empatica Inc.: News/Key Developments, 2023 and 2024\nTable 80: Evidation Health Inc.: Company Snapshot\nTable 81: Evidation Health Inc.: Product Portfolio\nTable 82: Evidation Health Inc.: News/Key Developments, 2022-2024\nTable 83: Feel Therapeutics: Company Snapshot\nTable 84: Feel Therapeutics: Product Portfolio\nTable 85: Feel Therapeutics: News/Key Developments, 2022 and 2023\nTable 86: Huma: Company Snapshot\nTable 87: Huma: Product Portfolio\nTable 88: Huma: News/Key Developments, 2023-2025\nTable 89: IXICO plc: Company Snapshot\nTable 90: IXICO plc: Financial Performance, FY 2023 and 2024\nTable 91: IXICO plc: Product Portfolio\nTable 92: IXICO plc: News/Key Developments, 2024 and 2025\nTable 93: Kinsa Inc.: Company Snapshot\nTable 94: Kinsa Inc.: Product Portfolio\nTable 95: Kinsa Inc.: News/Key Developments, 2024\nTable 96: Koneksa Health: Company Snapshot\nTable 97: Koneksa Health: Product Portfolio\nTable 98: Koneksa Health: News/Key Developments, 2023 and 2024\nTable 99: Neurotrack Technologies Inc.: Company Snapshot\nTable 100: Neurotrack Technologies Inc.: Product Portfolio\nTable 101: Neurotrack Technologies Inc.: News/Key Developments, 2022\nTable 102: VivoSensMedical GmbH: Company Snapshot\nTable 103: VivoSensMedical GmbH: Product Portfolio\nTable 104: VivoSensMedical GmbH: News/Key Developments, 2021\nTable 105: Winterlight Labs: Company Snapshot\nTable 106: Winterlight Labs: Product Portfolio\nList of Figures\nSummary Figure: Global Market Share of Digital Biomarkers, by Application, 2024\nFigure 1: PESTEL Analysis: Digital Biomarkers Market\nFigure 2: Digital Biomarkers Market Dynamics\nFigure 3: Distribution of Clinical Trials with Digital Biomarkers as Endpoints, by Therapeutic Area\nFigure 4: Global Market Shares of Digital Biomarkers, by System Component, 2024\nFigure 5: Global Digital Biomarkers Market Share of Data Collection Tools, by Type, 2024\nFigure 6: Global Digital Biomarkers Market Share of Mobile and Web Apps, by Region, 2024\nFigure 7: Global Digital Biomarkers Market Share of Wearables, by Region, 2024\nFigure 8: Global Digital Biomarkers Market Share of Implantables and Ingestibles, by Region, 2024\nFigure 9: Global Digital Biomarkers Market Share of Other Data Collection Tools, by Region, 2024\nFigure 10: Global Digital Biomarkers Market Share of Data Integration Systems, by Region, 2024\nFigure 11: Global Market Share of Digital Biomarkers, by Application, 2024\nFigure 12: Global Market Share of Diagnostic Digital Biomarkers, by Region, 2024\nFigure 13: Global Market Share of Monitoring Digital Biomarkers, by Region, 2024\nFigure 14: Global Market Share of Predictive Digital Biomarkers, by Region, 2024\nFigure 15: Global Market Share of Other Applications of Digital Biomarkers, by Region, 2024\nFigure 16: Global Market Share of Digital Biomarkers, by Therapeutic Area, 2024\nFigure 17: Global Digital Biomarkers Market Share of Cardiovascular and Metabolic Disorders, by Region, 2024\nFigure 18: Global Digital Biomarkers Market Share of Psychiatric Disorders, by Region, 2024\nFigure 19: Global Digital Biomarkers Market Share of Neurological Disorders, by Region, 2024\nFigure 20: Global Digital Biomarkers Market Share of Musculoskeletal Disorders, by Region, 2024\nFigure 21: Global Digital Biomarkers Market Share of Respiratory Disorders, by Region, 2024\nFigure 22: Global Digital Biomarkers Market Share of Other Therapeutic Areas, by Region, 2024\nFigure 23: Global Market Share of Digital Biomarkers, by End User, 2024\nFigure 24: Global Digital Biomarkers Market Share of Pharmaceutical Companies and Research Institutions, by Region, 2024\nFigure 25: Global Digital Biomarkers Market Share of Healthcare Providers, by Region, 2024\nFigure 26: Global Digital Biomarkers Market Share of Patients and Caregivers, by Region, 2024\nFigure 27: Global Digital Biomarkers Market Share of Employers, by Region, 2024\nFigure 28: Global Digital Biomarkers Market Share of Payers, by Region, 2024\nFigure 29: Global Market Share of Digital Biomarkers, by Region, 2024\nFigure 30: North American Market Share of Digital Biomarkers, by Country, 2024\nFigure 31: U.S. Elderly* Population, 2010-2050\nFigure 32: European Market Share of Digital Biomarkers, by Country, 2024\nFigure 33: Asia-Pacific Market Share of Digital Biomarkers, by Country, 2024\nFigure 34: RoW Market Share of Digital Biomarkers, by Sub-Region, 2024\nFigure 35: Digital Biomarkers: Competitor Types and Their Strategies\nFigure 36: Sustainability Factors in the Digital Biomarkers Industry\nFigure 37: Scaling Sustainable Practices in Healthcare\nFigure 38: IXICO plc: Revenue Share, by Country/Region, FY 2024"
    }
  ],
  "argos_summary": "The global digital biomarkers market is projected to grow from $5\u202fbillion in 2025 to $18.8\u202fbillion by 2030, a CAGR of 30.4%. The ResearchAndMarkets report outlines market size, drivers, challenges, ESG trends, and emerging AI/ML technologies, and profiles leading companies such as Actigraph, AliveCor, Altoida, Evidation Health, and IXICO. It segments the market by system component, application, therapeutic area, end\u2011user, and region, and analyzes regulatory landscapes across the U.S., Canada, Europe, and Asia\u2011Pacific. The report also highlights data standardization, validation, privacy issues, and opportunities in mHealth, neurodegenerative disorders, clinical trials, and corporate wellness.",
  "argos_id": "AKTQ1BW6F"
}